Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer-Reference-Cited by-同舟云学术

Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer

Published:2023-06 Issue: Volume:563 Page:216185
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Prajapati Dipakkumar R.,Molczyk Caitlin,Purohit Abhilasha,Saxena Sugandha,Sturgeon Reegan,Dave Bhavana J.,Kumar Sushil,Batra Surinder K.,Singh Rakesh K.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference66 articles.

1. Cancer statistics, 2023;Siegel;CA A Cancer J. Clin.,2023

2. Pancreatic cancer;Vincent;Lancet,2011

3. Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival;Desurmont;Cancer Sci.,2015

4. Differential expression profile of CXC-receptor-2 ligands as potential biomarkers in pancreatic ductal adenocarcinoma;Saxena;Am. J. Cancer Res.,2022

5. CXCR2 antagonists for the treatment of pulmonary disease;Chapman;Pharmacol. Therapeut.,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A microphysiological system reveals neutrophil contact-dependent attenuation of pancreatic tumor progression by CXCR2 inhibition-based immunotherapy;2023-12-04

2. Living Cell‐Derived Intelligent Nanobots for Precision Oncotherapy;Advanced Functional Materials;2023-11-23

3. Current progress of immune checkpoint inhibitors for advanced colorectal cancer: concentrating on the efficacy improvement;Critical Reviews in Oncology/Hematology;2023-11

4. Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment;Biomedicines;2023-09-24